GlassScriptPhysician profile
Tarone Thirawatananond
NPI 1366187916
$1,323.00
in general payments reported to CMS, 2019-2025
9 companies · $500 in 2025
The $500 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $97.70 · 2023: $454 · 2024: $272 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.49 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $347.68 | 2022-2025 | Exparel |
| Heron Therapeutics, INC. | $249.98 | 2025 | Zynrelef, Aponvie |
| Cumberland Pharmaceuticals, INC. | $130.69 | 2024 | Caldolor |
| Medical Device Business Services, INC. | $124.99 | 2024 | Surgicel Nu-Knit |
| Insmed, INC. | $117.41 | 2023 | Arikayce |
| Merck Sharp & Dohme LLC | $114.88 | 2023 | Bridion |
| Astrazeneca Pharmaceuticals LP | $111.82 | 2023 | Andexxa |
| Chiesi USA, INC. | $96.19 | 2023 | Cleviprex |
| Fisher & Paykel Healthcare INC | $29.36 | 2023-2024 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarone Thirawatananond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.